<DOC>
	<DOCNO>NCT00555789</DOCNO>
	<brief_summary>This study provide continue treatment ass long term safety , efficacy tolerability oral AEB071 plus tacrolimus vs. mycophenolic acid plus tacrolimus kidney transplantation .</brief_summary>
	<brief_title>24 Month Extension Efficacy Safety AEB071 Plus Tacrolimus ( Converted Mycophenolic Acid After 3 Months ) Renal Transplant Patients ( Converted Mycophenolic Acid After 3 Months ) Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion criterion : Participation core study CAEB071A2203 The patient maintain AEB071/mycophenolic acid tacrolimus/mycophenolic acid , consistent original randomization , core study Month 12 visit . Women capable become pregnant require practice medically approve method birth control long study medication period 3 month follow discontinuation study drug ( ) . Exclusion criterion : Pregnancy . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>kidney transplantation</keyword>
	<keyword>rejection</keyword>
	<keyword>AEB071</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>mycophenolic acid</keyword>
	<keyword>immunosuppression</keyword>
</DOC>